Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
מצבים רפואיים
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8 · Anatomic Stage IB Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Endocrine Therapy-Induced Alopecia · Prognostic Stage I Breast Cancer AJCC v8 · Prognostic Stage IA Breast Cancer AJCC v8 · Prognostic Stage IB Breast Cancer AJCC v8 · Prognostic Stage II Breast Cancer AJCC v8 · Prognostic Stage IIA Breast Cancer AJCC v8 · Prognostic Stage IIB Breast Cancer AJCC v8 · Prognostic Stage III Breast Cancer AJCC v8 · Prognostic Stage IIIA Breast Cancer AJCC v8 · Prognostic Stage IIIB Breast Cancer AJCC v8 · Prognostic Stage IIIC Breast Cancer AJCC v8 · Prognostic Stage IV Breast Cancer AJCC v8
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Brittany L. Dulmage, MD)
מובילי המחקר
Brittany L Dulmage, MD
Principal Investigator
Ohio State University Comprehensive Cancer Center